The FDA granted Fast Track designation to Lu AH69593, a treatment associated with Lundbeck.
1 report, 1 independent
Updated Jul 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA granted Fast Track designation to Lu AH69593, a treatment associated with Lundbeck.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Food and Drug Administration
government organization in Nonthaburi, Thailand
-
Lundbeck
Danish pharmaceutical company
Coverage
Newest first; wire copies grouped- neurologyadvisor.comFDA Fast Tracks Lundbeck’s OX2R Agonist for Narcolepsy